Minamestane
Minamestane (FCE 24928) is a selective and competitive aromatase inhibitor with an IC50 value of 45.7 nM. Minamestane is promising for research of postmenopausal breast cancer[1].
Product Specifications
CAS Number
105051-87-4
Product Name Alternative
FCE 24928
UNSPSC
12352211
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/minamestane.html
Smiles
C[C@@]12[C@]3([H])[C@](C=CC1=C(C(C=C2)=O)N)([H])[C@@]4([H])[C@](CC3)(C(CC4)=O)C
Molecular Formula
C19H23NO2
Molecular Weight
297.39
References & Citations
[1]Di Salle E, et al. Novel aromatase and 5α-reductase inhibitors[J]. The Journal of Steroid Biochemistry and Molecular Biology, 1994, 49 (4-6) : 289-294.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GP-7401-5 1 mL
Colloidal Gold Conjugated Galanthus nivalis Lectin (Snowdrop Bulb) -GNA-, 5nm
Sign In for Pricing
View Details 
TRC-T795270-1MG 1 mg
3Alpha,17,20Beta-Trihydroxy-5Beta-pregnan-11-one
Sign In for Pricing
View Details 
ICH1211LALAPG-20mg 20 mg
Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody (LALAPG)
Sign In for Pricing
View Details